| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |